Nagahama Kanji, Nishimura Eiji, Sakaguchi Shimon
Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.
Methods Mol Biol. 2007;380:431-42. doi: 10.1007/978-1-59745-395-0_27.
Naturally arising CD4+CD25+ regulatory T (Treg) cells can be exploited to establish immunologic tolerance to allogeneic transplants. In vivo exposure of CD4+CD25+ T cells from normal naive mice to alloantigen in a T cell-deficient environment elicits spontaneous expansion of alloantigen-specific CD4+CD25+ natural Treg cells, which are able to suppress allograft rejection mediated by subsequently transferred naive T cells, leading to long-term graft tolerance. Similar antigen-specific expansion of natural Treg cells can also be achieved in vitro by stimulating CD4+CD25+ T cells from normal animals with alloantigen in the presence of high doses of interleukin-2. The expanded CD4+CD25+ Treg cells are even capable of suppressing secondary mixed leukocyte reaction in vitro and, by in vivo transfer, establishing antigen-specific long-term graft tolerance. Thus, in vivo or in vitro, direct or indirect ways of alloantigen-specific expansion of naturally arising CD4+CD25+ Treg cells can establish antigen-specific dominant tolerance to allogeneic transplants.
天然产生的CD4+CD25+调节性T(Treg)细胞可用于建立对同种异体移植的免疫耐受。在T细胞缺陷环境中,将正常未致敏小鼠的CD4+CD25+T细胞体内暴露于同种异体抗原,可引发同种异体抗原特异性CD4+CD25+天然Treg细胞的自发扩增,这些细胞能够抑制随后转移的未致敏T细胞介导的同种异体移植排斥反应,从而导致长期的移植物耐受。通过在高剂量白细胞介素-2存在的情况下用同种异体抗原刺激正常动物的CD4+CD25+T细胞,也可在体外实现天然Treg细胞的类似抗原特异性扩增。扩增后的CD4+CD25+Treg细胞甚至能够在体外抑制二次混合淋巴细胞反应,并通过体内转移建立抗原特异性长期移植物耐受。因此,无论在体内还是体外,天然产生的CD4+CD25+Treg细胞同种异体抗原特异性扩增的直接或间接方式均可建立对同种异体移植的抗原特异性显性耐受。